{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T07:56:05Z","timestamp":1791618965353,"version":"4.3.4"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T00:00:00Z","timestamp":1674604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T00:00:00Z","timestamp":1674604800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Eosinophilic esophagitis (EoE) is a chronic immune-mediated rare disease, characterized by esophageal dysfunctions. It is likely to be primarily activated by food antigens and is classified as a chronic disease for most patients. Therefore, a deeper understanding of the pathogenetic mechanisms underlying EoE is needed to implement and improve therapeutic lines of intervention and ameliorate overall patient wellness.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>RNA-seq data of 18 different studies on EoE, downloaded from NCBI GEO with faster-qdump (<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/github.com\/ncbi\/sra-tools\">https:\/\/github.com\/ncbi\/sra-tools<\/jats:ext-link>), were batch-corrected and analyzed for transcriptomics and metatranscriptomics profiling as well as biological process functional enrichment. The EoE TaMMA web app was designed with plotly and dash. Tabula Sapiens raw data were downloaded from the UCSC Cell Browser. Esophageal single-cell raw data analysis was performed within the Automated Single-cell Analysis Pipeline. Single-cell data-driven bulk RNA-seq data deconvolution was performed with MuSiC and CIBERSORTx. Multi-omics integration was performed with MOFA.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The EoE TaMMA framework pointed out disease-specific molecular signatures, confirming its reliability in reanalyzing transcriptomic data, and providing new EoE-specific molecular markers including CXCL14, distinguishing EoE from gastroesophageal reflux disorder. EoE TaMMA also revealed microbiota dysbiosis as a predominant characteristic of EoE pathogenesis. Finally, the multi-omics analysis highlighted the presence of defined classes of microbial entities in subsets of patients that may participate in inducing the antigen-mediated response typical of EoE pathogenesis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our study showed that the complex EoE molecular network may be unraveled through advanced bioinformatics, integrating different components of the disease process into an omics-based network approach. This may implement EoE management and treatment in the coming years.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12967-023-03898-x","type":"journal-article","created":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T06:02:48Z","timestamp":1674626568000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["A multi-omic analysis reveals the esophageal dysbiosis as the predominant trait of eosinophilic esophagitis"],"prefix":"10.1186","volume":"21","author":[{"given":"Luca","family":"Massimino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Barchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco Vito","family":"Mandarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Span\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi Antonio","family":"Lamparelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Vespa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro","family":"Passaretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Peyrin-Biroulet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo Vincenzo","family":"Savarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vipul","family":"Jairath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5395-7795","authenticated-orcid":false,"given":"Federica","family":"Ungaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvio","family":"Danese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,25]]},"reference":[{"key":"3898_CR1","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1056\/NEJMra1502863","volume":"373","author":"GT Furuta","year":"2015","unstructured":"Furuta GT, Katzka DA. Eosinophilic esophagitis. N Engl J Med. 2015;373:1640\u20138.","journal-title":"N Engl J Med"},{"key":"3898_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/apt.13441","volume":"43","author":"\u00c1 Arias","year":"2016","unstructured":"Arias \u00c1, P\u00e9rez-Mart\u00ednez I, Ten\u00edas JM, Lucendo AJ. Systematic review with meta-analysis: the incidence and prevalence of eosinophilic oesophagitis in children and adults in population-based studies. Aliment Pharmacol Ther. 2016;43:3\u201315.","journal-title":"Aliment Pharmacol Ther"},{"key":"3898_CR3","doi-asserted-by":"publisher","first-page":"2928","DOI":"10.1007\/s10620-016-4204-4","volume":"61","author":"E Mansoor","year":"2016","unstructured":"Mansoor E, Cooper GS. The 2010\u20132015 prevalence of eosinophilic esophagitis in the USA: a population-based study. Dig Dis Sci. 2016;61:2928\u201334.","journal-title":"Dig Dis Sci"},{"key":"3898_CR4","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1053\/j.gastro.2011.06.081","volume":"141","author":"ES Dellon","year":"2011","unstructured":"Dellon ES, Peery AF, Shaheen NJ, Morgan DR, Hurrell JM, Lash RH, et al. Inverse association of esophageal eosinophilia with Helicobacter pylori based on analysis of a US pathology database. Gastroenterology. 2011;141:1586\u201392.","journal-title":"Gastroenterology"},{"key":"3898_CR5","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/ng.3033","volume":"46","author":"LC Kottyan","year":"2014","unstructured":"Kottyan LC, Davis BP, Sherrill JD, Liu K, Rochman M, Kaufman K, et al. Genome-wide association analysis of eosinophilic esophagitis provides insight into the tissue specificity of this allergic disease. Nat Genet. 2014;46:895\u2013900.","journal-title":"Nat Genet"},{"key":"3898_CR6","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1053\/j.gastro.2021.04.080","volume":"161","author":"C Ma","year":"2021","unstructured":"Ma C, Schoepfer AM, Safroneeva E, COREOS Collaborators. Development of a core outcome set for therapeutic studies in\u00a0eosinophilic esophagitis (COREOS): an international multidisciplinary consensus. Gastroenterology. 2021;161:748\u201355.","journal-title":"Gastroenterology"},{"key":"3898_CR7","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1111\/apt.17091","volume":"56","author":"S Facchin","year":"2022","unstructured":"Facchin S, Calgaro M, Pandolfo M, Caldart F, Ghisa M, Greco E, et al. Salivary microbiota composition may discriminate between patients with eosinophilic oesophagitis (EoE) and non-EoE subjects. Aliment Pharmacol Ther. 2022;56:450\u201362.","journal-title":"Aliment Pharmacol Ther"},{"key":"3898_CR8","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1038\/s41395-018-0052-5","volume":"113","author":"MJ Warners","year":"2018","unstructured":"Warners MJ, Oude Nijhuis RAB, de Wijkerslooth LRH, Smout AJPM, Bredenoord AJ. The natural course of eosinophilic esophagitis and long-term consequences of undiagnosed disease in a large cohort. Am J Gastroenterol. 2018;113:836\u201344.","journal-title":"Am J Gastroenterol"},{"key":"3898_CR9","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/s43588-021-00114-y","volume":"1","author":"L Massimino","year":"2021","unstructured":"Massimino L, Lamparelli LA, Houshyar Y, D\u2019Alessio S, Peyrin-Biroulet L, Vetrano S, et al. The inflammatory bowel disease transcriptome and metatranscriptome meta-analysis (IBD TaMMA) framework. Nat Comput Sci. 2021;1:511\u20135.","journal-title":"Nat Comput Sci"},{"key":"3898_CR10","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/s43588-021-00124-w","volume":"1","author":"D Modos","year":"2021","unstructured":"Modos D, Thomas JP, Korcsmaros T. A handy meta-analysis tool for IBD research. Nat Comput Sci. 2021;1:571.","journal-title":"Nat Comput Sci."},{"key":"3898_CR11","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 2014;30:2114\u201320.","journal-title":"Bioinformatics"},{"key":"3898_CR12","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/978-1-4939-3572-7_13","volume":"1415","author":"A Dobin","year":"2016","unstructured":"Dobin A, Gingeras TR. Optimizing RNA-Seq mapping with STAR. Methods Mol Biol. 2016;1415:245\u201362.","journal-title":"Methods Mol Biol"},{"key":"3898_CR13","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.","journal-title":"Genome Biol"},{"key":"3898_CR14","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1186\/s12859-016-1250-z","volume":"17","author":"S Subhash","year":"2016","unstructured":"Subhash S, Kanduri C. GeneSCF: a real-time based functional enrichment tool with support for multiple organisms. BMC Bioinform. 2016;17:365.","journal-title":"BMC Bioinform"},{"key":"3898_CR15","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1080\/19490976.2018.1511664","volume":"10","author":"F Ungaro","year":"2019","unstructured":"Ungaro F, Massimino L, Furfaro F, Rimoldi V, Peyrin-Biroulet L, D\u2019Alessio S, et al. Metagenomic analysis of intestinal mucosa revealed a specific eukaryotic gut virome signature in early-diagnosed inflammatory bowel disease. Gut Microbes. 2019;10:149\u201358.","journal-title":"Gut Microbes"},{"key":"3898_CR16","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12859-015-0478-3","volume":"16","author":"CK Stein","year":"2015","unstructured":"Stein CK, Qu P, Epstein J, Buros A, Rosenthal A, Crowley J, et al. Removing batch effects from purified plasma cell gene expression microarrays with modified ComBat. BMC Bioinform. 2015;16:63.","journal-title":"BMC Bioinform"},{"key":"3898_CR17","doi-asserted-by":"publisher","first-page":"R46","DOI":"10.1186\/gb-2014-15-3-r46","volume":"15","author":"DE Wood","year":"2014","unstructured":"Wood DE, Salzberg SL. Kraken: ultrafast metagenomic sequence classification using exact alignments. Genome Biol. 2014;15:R46.","journal-title":"Genome Biol"},{"key":"3898_CR18","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/bib\/bbs017","volume":"14","author":"H Thorvaldsd\u00f3ttir","year":"2013","unstructured":"Thorvaldsd\u00f3ttir H, Robinson JT, Mesirov JP. Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration. Brief Bioinform. 2013;14:178\u201392.","journal-title":"Brief Bioinform"},{"issue":"Web Server issu","key":"3898_CR19","doi-asserted-by":"publisher","first-page":"W5","DOI":"10.1093\/nar\/gkn201","volume":"36","author":"M Johnson","year":"2008","unstructured":"Johnson M, Zaretskaya I, Raytselis Y, Merezhuk Y, McGinnis S, Madden TL. NCBI BLAST: a better web interface. Nucleic Acids Res. 2008;36(Web Server issue):W5-9.","journal-title":"Nucleic Acids Res"},{"key":"3898_CR20","unstructured":"The Tabula Sapiens Consortium, Quake SR. The Tabula Sapiens: a single cell transcriptomic atlas of multiple organs from individual human donors. BioRxiv. 2021."},{"key":"3898_CR21","doi-asserted-by":"publisher","first-page":"eabi5586","DOI":"10.1126\/sciimmunol.abi5586","volume":"6","author":"DM Morgan","year":"2021","unstructured":"Morgan DM, Ruiter B, Smith NP, Tu AA, Monian B, Stone BE, et al. Clonally expanded, GPR15-expressing pathogenic effector TH2 cells are associated with eosinophilic esophagitis. Sci Immunol. 2021;6:eabi5586.","journal-title":"Sci Immunol."},{"key":"3898_CR22","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.1093\/bioinformatics\/btx337","volume":"33","author":"V Gardeux","year":"2017","unstructured":"Gardeux V, David FPA, Shajkofci A, Schwalie PC, Deplancke B. ASAP: a web-based platform for the analysis and interactive visualization of single-cell RNA-seq data. Bioinformatics. 2017;33:3123\u20135.","journal-title":"Bioinformatics"},{"key":"3898_CR23","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/s41467-018-08023-x","volume":"10","author":"X Wang","year":"2019","unstructured":"Wang X, Park J, Susztak K, Zhang NR, Li M. Bulk tissue cell type deconvolution with multi-subject single-cell expression reference. Nat Commun. 2019;10:380.","journal-title":"Nat Commun"},{"key":"3898_CR24","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","volume":"37","author":"AM Newman","year":"2019","unstructured":"Newman AM, Steen CB, Liu CL, Gentles AJ, Chaudhuri AA, Scherer F, et al. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat Biotechnol. 2019;37:773\u201382.","journal-title":"Nat Biotechnol"},{"key":"3898_CR25","doi-asserted-by":"publisher","DOI":"10.15252\/msb.20178124","volume":"14","author":"R Argelaguet","year":"2018","unstructured":"Argelaguet R, Velten B, Arnol D, Dietrich S, Zenz T, Marioni JC, et al. Multi-omics factor analysis-a framework for unsupervised integration of multi-omics data sets. Mol Syst Biol. 2018;14: e8124.","journal-title":"Mol Syst Biol"},{"key":"3898_CR26","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1053\/j.gastro.2017.06.065","volume":"154","author":"KM O\u2019Shea","year":"2018","unstructured":"O\u2019Shea KM, Aceves SS, Dellon ES, Gupta SK, Spergel JM, Furuta GT, et al. Pathophysiology of eosinophilic esophagitis. Gastroenterology. 2018;154:333\u201345.","journal-title":"Gastroenterology"},{"key":"3898_CR27","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1016\/j.humpath.2007.05.008","volume":"38","author":"B Bhattacharya","year":"2007","unstructured":"Bhattacharya B, Carlsten J, Sabo E, Kethu S, Meitner P, Tavares R, et al. Increased expression of eotaxin-3 distinguishes between eosinophilic esophagitis and gastroesophageal reflux disease. Hum Pathol. 2007;38:1744\u201353.","journal-title":"Hum Pathol"},{"key":"3898_CR28","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.86355","volume":"1","author":"BP Davis","year":"2016","unstructured":"Davis BP, Stucke EM, Khorki ME, Litosh VA, Rymer JK, Rochman M, et al. Eosinophilic esophagitis-linked calpain 14 is an IL-13-induced protease that mediates esophageal epithelial barrier impairment. JCI Insight. 2016;1: e86355.","journal-title":"JCI Insight"},{"key":"3898_CR29","volume":"3","author":"MK Jaakkola","year":"2021","unstructured":"Jaakkola MK, Elo LL. Computational deconvolution to estimate cell type-specific gene expression from bulk data. NAR Genom Bioinform. 2021;3: lqaa110.","journal-title":"NAR Genom Bioinform."},{"key":"3898_CR30","doi-asserted-by":"publisher","DOI":"10.1126\/science.abl4896","volume":"376","author":"RC Jones","year":"2022","unstructured":"Tabula Sapiens Consortium*, Jones RC, Karkanias J, Krasnow MA, Pisco AO, Quake SR, et al. The Tabula Sapiens: a multiple-organ, single-cell transcriptomic atlas of humans. Science. 2022;376: eabl4896.","journal-title":"Science"},{"key":"3898_CR31","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/mi.2010.88","volume":"4","author":"DJ Mulder","year":"2011","unstructured":"Mulder DJ, Justinich CJ. Understanding eosinophilic esophagitis: the cellular and molecular mechanisms of an emerging disease. Mucosal Immunol. 2011;4:139\u201347.","journal-title":"Mucosal Immunol"},{"key":"3898_CR32","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/ajg.2014.12","volume":"109","author":"WS Lexmond","year":"2014","unstructured":"Lexmond WS, Neves JF, Nurko S, Olszak T, Exley MA, Blumberg RS, et al. Involvement of the iNKT cell pathway is associated with early-onset eosinophilic esophagitis and response to allergen avoidance therapy. Am J Gastroenterol. 2014;109:646\u201357.","journal-title":"Am J Gastroenterol"},{"key":"3898_CR33","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/JLB.5MR1017-395R","volume":"104","author":"J Armbruster-Lee","year":"2018","unstructured":"Armbruster-Lee J, Cavender CP, Lieberman JA, Samarasinghe AE. Understanding fibrosis in eosinophilic esophagitis: are we there yet? J Leukoc Biol. 2018;104:31\u201340.","journal-title":"J Leukoc Biol"},{"key":"3898_CR34","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1172\/JCI200320530","volume":"112","author":"R Kalluri","year":"2003","unstructured":"Kalluri R, Neilson EG. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest. 2003;112:1776\u201384.","journal-title":"J Clin Invest"},{"key":"3898_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12950-015-0109-9","volume":"13","author":"J Lu","year":"2016","unstructured":"Lu J, Chatterjee M, Schmid H, Beck S, Gawaz M. CXCL14 as an emerging immune and inflammatory modulator. J Inflamm (Lond). 2016;13:1.","journal-title":"J Inflamm (Lond)"},{"key":"3898_CR36","doi-asserted-by":"publisher","first-page":"7113","DOI":"10.1038\/s41598-021-86464-z","volume":"11","author":"EJ Laserna-Mendieta","year":"2021","unstructured":"Laserna-Mendieta EJ, FitzGerald JA, Arias-Gonzalez L, Ollala JM, Bernardo D, Claesson MJ, et al. Esophageal microbiome in active eosinophilic esophagitis and changes induced by different therapies. Sci Rep. 2021;11:7113.","journal-title":"Sci Rep"},{"key":"3898_CR37","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s40168-015-0085-6","volume":"3","author":"AJ Benitez","year":"2015","unstructured":"Benitez AJ, Hoffmann C, Muir AB, Dods KK, Spergel JM, Bushman FD, et al. Inflammation-associated microbiota in pediatric eosinophilic esophagitis. Microbiome. 2015;3:23.","journal-title":"Microbiome"},{"key":"3898_CR38","doi-asserted-by":"publisher","first-page":"e109","DOI":"10.1097\/MPG.0000000000003413","volume":"74","author":"KR Parashette","year":"2022","unstructured":"Parashette KR, Sarsani VK, Toh E, Janga SC, Nelson DE, Gupta SK. Esophageal microbiome in healthy children and esophageal eosinophilia. J Pediatr Gastroenterol Nutr. 2022;74:e109\u201314.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"3898_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.631011","volume":"9","author":"L Ning","year":"2021","unstructured":"Ning L, Huixin H. Topic evolution analysis for omics data integration in cancers. Front Cell Dev Biol. 2021;9: 631011.","journal-title":"Front Cell Dev Biol"},{"key":"3898_CR40","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1177\/2050640619876787","volume":"7","author":"F Ungaro","year":"2019","unstructured":"Ungaro F, Massimino L, D\u2019Alessio S, Danese S. The gut virome in inflammatory bowel disease pathogenesis: from metagenomics to novel therapeutic approaches. United Eur Gastroenterol J. 2019;7:999\u20131007.","journal-title":"United Eur Gastroenterol J"},{"key":"3898_CR41","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1038\/s41467-022-29998-8","volume":"13","author":"J Brooks-Warburton","year":"2022","unstructured":"Brooks-Warburton J, Modos D, Sudhakar P, Madgwick M, Thomas JP, Bohar B, et al. A systems genomics approach to uncover patient-specific pathogenic pathways and proteins in ulcerative colitis. Nat Commun. 2022;13:2299.","journal-title":"Nat Commun"},{"key":"3898_CR42","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1053\/j.gastro.2018.07.009","volume":"155","author":"ES Dellon","year":"2018","unstructured":"Dellon ES, Liacouras CA, Molina-Infante J, Furuta GT, Spergel JM, Zevit N, et al. Updated international consensus diagnostic criteria for eosinophilic esophagitis: proceedings of the AGREE conference. Gastroenterology. 2018;155:1022-1033.e10.","journal-title":"Gastroenterology"},{"key":"3898_CR43","doi-asserted-by":"publisher","first-page":"2822","DOI":"10.3390\/ijms22062822","volume":"22","author":"EI Vlachavas","year":"2021","unstructured":"Vlachavas EI, Bohn J, \u00dcckert F, N\u00fcrnberg S. A detailed catalogue of multi-omics methodologies for identification of putative biomarkers and causal molecular networks in translational cancer research. Int J Mol Sci. 2021;22:2822.","journal-title":"Int J Mol Sci"},{"key":"3898_CR44","doi-asserted-by":"publisher","first-page":"2081476","DOI":"10.1080\/19490976.2022.2081476","volume":"14","author":"P Gonz\u00e1lez-D\u00e1vila","year":"2022","unstructured":"Gonz\u00e1lez-D\u00e1vila P, Schwalbe M, Danewalia A, Wardenaar R, Dalile B, Verbeke K, et al. Gut microbiota transplantation drives the adoptive transfer of colonic genotype-phenotype characteristics between mice lacking catestatin and their wild type counterparts. Gut Microbes. 2022;14:2081476.","journal-title":"Gut Microbes"},{"key":"3898_CR45","doi-asserted-by":"publisher","first-page":"13183","DOI":"10.3390\/ijms222413183","volume":"22","author":"YV Zhernov","year":"2021","unstructured":"Zhernov YV, Vysochanskaya SO, Sukhov VA, Zaostrovtseva OK, Gorshenin DS, Sidorova EA, et al. Molecular mechanisms of eosinophilic esophagitis. Int J Mol Sci. 2021;22:13183.","journal-title":"Int J Mol Sci"},{"key":"3898_CR46","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1053\/j.gastro.2019.09.042","volume":"158","author":"I Hirano","year":"2020","unstructured":"Hirano I, Dellon ES, Hamilton JD, Collins MH, Peterson K, Chehade M, et al. Efficacy of dupilumab in a phase 2 randomized trial of adults with active eosinophilic esophagitis. Gastroenterology. 2020;158:111-122.e10.","journal-title":"Gastroenterology"},{"key":"3898_CR47","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1136\/gutjnl-2012-302250","volume":"62","author":"E Cheng","year":"2013","unstructured":"Cheng E, Zhang X, Huo X, Yu C, Zhang Q, Wang DH, et al. Omeprazole blocks eotaxin-3 expression by oesophageal squamous cells from patients with eosinophilic oesophagitis and GORD. Gut. 2013;62:824\u201332.","journal-title":"Gut"},{"key":"3898_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0050037","volume":"7","author":"X Zhang","year":"2012","unstructured":"Zhang X, Cheng E, Huo X, Yu C, Zhang Q, Pham TH, et al. Omeprazole blocks STAT6 binding to the eotaxin-3 promoter in eosinophilic esophagitis cells. PLoS ONE. 2012;7: e50037.","journal-title":"PLoS ONE"},{"key":"3898_CR49","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1053\/j.gastro.2021.02.016","volume":"160","author":"E Odiase","year":"2021","unstructured":"Odiase E, Zhang X, Chang Y, Nelson M, Balaji U, Gu J, et al. In esophageal squamous cells from eosinophilic esophagitis patients, Th2 cytokines increase Eotaxin-3 secretion through effects on intracellular calcium and a non-gastric proton pump. Gastroenterology. 2021;160:2072.","journal-title":"Gastroenterology"},{"key":"3898_CR50","doi-asserted-by":"publisher","DOI":"10.1128\/mSphere.00040-17","volume":"2","author":"K Cater","year":"2017","unstructured":"Cater K, Dandu VS, Bari SMN, Lackey K, Everett GFK, Hatoum-Aslan A. A novel staphylococcus podophage encodes a unique lysin with unusual modular design. mSphere. 2017;2: e00040.","journal-title":"mSphere."},{"key":"3898_CR51","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.jaip.2017.02.004","volume":"5","author":"JP Abonia","year":"2017","unstructured":"Abonia JP, Spergel JM, Cianferoni A. Eosinophilic esophagitis: a primary disease of the esophageal mucosa. J Allergy Clin Immunol Pract. 2017;5:951\u20135.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"3898_CR52","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.ygeno.2018.08.008","volume":"111","author":"M Yazdi","year":"2019","unstructured":"Yazdi M, Bouzari M, Ghaemi EA. Genomic analyses of a novel bacteriophage (VB_PmiS-Isfahan) within Siphoviridae family infecting Proteus mirabilis. Genomics. 2019;111:1283\u201391.","journal-title":"Genomics"},{"key":"3898_CR53","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00085-17","volume":"31","author":"AL Hamilton","year":"2018","unstructured":"Hamilton AL, Kamm MA, Ng SC, Morrison M. Proteus spp. as putative gastrointestinal pathogens. Clin Microbiol Rev. 2018;31: e00085.","journal-title":"Clin Microbiol Rev"},{"key":"3898_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.783295","volume":"12","author":"Y Houshyar","year":"2021","unstructured":"Houshyar Y, Massimino L, Lamparelli LA, Danese S, Ungaro F. Going beyond bacteria: uncovering the role of archaeome and mycobiome in inflammatory bowel disease. Front Physiol. 2021;12: 783295.","journal-title":"Front Physiol"},{"key":"3898_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.651060","volume":"12","author":"M Nordengr\u00fcn","year":"2021","unstructured":"Nordengr\u00fcn M, Abdurrahman G, Treffon J, W\u00e4chter H, Kahl BC, Br\u00f6ker BM. Allergic reactions to serine protease-like proteins of Staphylococcus aureus. Front Immunol. 2021;12: 651060.","journal-title":"Front Immunol"},{"key":"3898_CR56","volume-title":"Allergens and allergen immunotherapy subcutaneous sublingual and oral. 6th, illustrated edition","year":"2020","unstructured":"Lockey RF, Ledford DK, editors. Allergens and allergen immunotherapy subcutaneous sublingual and oral. 6th, illustrated edition. Boca Raton: CRC Press; 2020."},{"key":"3898_CR57","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.3389\/fmicb.2015.01273","volume":"6","author":"D Hildebrand","year":"2015","unstructured":"Hildebrand D, Heeg K, Kubatzky KF. Pasteurella multocida toxin manipulates T cell differentiation. Front Microbiol. 2015;6:1273.","journal-title":"Front Microbiol"},{"key":"3898_CR58","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12936-022-04131-8","volume":"21","author":"W-C Lee","year":"2022","unstructured":"Lee W-C, Cheong FW, Amir A, Lai MY, Tan JH, Phang WK, et al. Plasmodium knowlesi: the game changer for malaria eradication. Malar J. 2022;21:140.","journal-title":"Malar J"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-03898-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-023-03898-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-03898-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T06:05:36Z","timestamp":1674626736000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-023-03898-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,25]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3898"],"URL":"https:\/\/doi.org\/10.1186\/s12967-023-03898-x","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,25]]},"assertion":[{"value":"3 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"SD has served as a speaker, consultant, and advisory board member for Schering Plough, Abbott (AbbVie) Laboratories, Merck and Co, UCB Pharma, Ferring, Cellerix, Millenium Takeda, Nycomed, Pharmacosmos, Actelion, Alfa Wasserman, Genentech, Grunenthal, Pfizer, AstraZeneca, Novo Nordisk, Vifor, and Johnson and Johnson. LPB has served as consultant for Merck, Abbvie, Janssen, Genentech, Ferring, Tillots, Vifor, Pharmacosmos, Celltrion, Takeda, Biogaran, Boerhinger-lngelheim, Lilly, Pfizer, Jndex Pharmaceuticals, Amgen, Sandoz, Celgene, Biogen, Samsung Bioepis, Alma, Sterna, Nestl\u00e9, Enterome, Mylan, HAC-Pharma, Tigenix, and has served as speaker for Merck, Abbvie, Janssen, Genentech, Ferring, Tillots, Vifor, Pharmacosmos, Celltrion, Takeda, Boerhinger-lngelheim, Pfizer, Amgen, Biogen, Samsung Bioepis. ES declares lecture fees from Takeda, Janssen, MSD, Abbvie, Malesci, Sofar, and consulting fees from BMS, Gilead, Takeda, Janssen, MSD, Reckitt Benckiser, Sofar, Unifarco, SILA, Oftagest, Diadema. VJ has received consulting\/advisory board fees from AbbVie, Alimentiv Inc (formerly Robarts Clinical Trials), Arena pharmaceuticals, Asieris, Bristol Myers Squibb, Celltrion, Eli Lilly, Ferring, Fresenius Kabi, Galapagos, GlaxoSmithKline, Genetech, Gilead, Janssen, Merck, Mylan, Pandion, Pendopharm, Pfizer, Reistone Biopharma, Roche, Sandoz, Takeda, Teva, and Topivert; speaker's fees from AbbVie, Ferring, Galapagos, Janssen Pfizer Shire, and Takeda. The other authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"46"}}